Bionik Laboratories Corp.·4

Jun 4, 3:57 PM ET

MARKOW LESLIE NADENE 4

4 · Bionik Laboratories Corp. · Filed Jun 4, 2019

Insider Transaction Report

Form 4
Period: 2019-05-31
MARKOW LESLIE NADENE
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-05-31+7,4007,400 total
    Exercise: $3.16Exp: 2026-05-31Common Stock, par value $0.001 (7,400 underlying)
Footnotes (1)
  • [F1]The options vest 2,466 on May 31, 2019, 2,466 on November 30, 2019 and 2,468 on May 31, 2020.

Documents

1 file
  • 4
    tv523054_4.xmlPrimary

    OWNERSHIP DOCUMENT